Iovance Biotherapeutics Poised for Strong Market Position and Financial Growth: Buy Rating Affirmed

TipRanks12:55 ET · Ratings

Iovance Biotherapeutics Second Quarter 2024 Earnings: Beats Expectations

Yahoo FinanceAug 10 08:31 ET

Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday

BenzingaAug 9 12:51 ET

Skin Cancer-Focused Iovance Biotherapeutics Reports Better-Than-Expected 2024, 2025 Outlook, Stock Surges

BenzingaAug 9 11:20 ET

Market-Moving News for August 9th

BenzingaAug 9 08:16 ET

Encouraging Jobless Claims Buoy Exchange-Traded Funds, Equity Futures Pre-Bell Friday

MT NewswiresAug 9 08:04 ET